| 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the … SV Konstantinides, G Meyer, C Becattini, H Bueno, GJ Geersing, ... European heart journal 41 (4), 543-603, 2020 | 4412 | 2020 |
| Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial N Galiè, M Humbert, JL Vachiéry, CD Vizza, M Kneussl, A Manes, ... Journal of the American College of Cardiology 39 (9), 1496-1502, 2002 | 925* | 2002 |
| Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model MM Hoeper, T Kramer, Z Pan, CA Eichstaedt, J Spiesshoefer, N Benjamin, ... European Respiratory Journal 50 (2), 2017 | 662 | 2017 |
| Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry MM Hoeper, D Huscher, HA Ghofrani, M Delcroix, O Distler, C Schweiger, ... International journal of cardiology 168 (2), 871-880, 2013 | 509 | 2013 |
| Right and left ventricular dysfunction in patients with severe pulmonary disease CD Vizza, JP Lynch, LL Ochoa, G Richardson, EP Trulock Chest 113 (3), 576-583, 1998 | 443 | 1998 |
| Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension … KM Olsson, M Delcroix, HA Ghofrani, H Tiede, D Huscher, R Speich, ... Circulation 129 (1), 57-65, 2014 | 426 | 2014 |
| Pregnancy outcomes in pulmonary arterial hypertension in the modern management era X Jaïs, KM Olsson, JA Barbera, I Blanco, A Torbicki, A Peacock, CD Vizza, ... European Respiratory Journal 40 (4), 881-885, 2012 | 316 | 2012 |
| Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum CF Opitz, MM Hoeper, JSR Gibbs, H Kaemmerer, J Pepke-Zaba, ... Journal of the American College of Cardiology 68 (4), 368-378, 2016 | 299 | 2016 |
| Prostanoid therapy for pulmonary arterial hypertension DB Badesch, VV McLaughlin, M Delcroix, CD Vizza, H Olschewski, ... Journal of the American College of Cardiology 43 (12S), S56-S61, 2004 | 281 | 2004 |
| An official European Respiratory Society statement: pulmonary haemodynamics during exercise G Kovacs, P Herve, JA Barbera, A Chaouat, D Chemla, R Condliffe, ... European Respiratory Journal 50 (5), 2017 | 272 | 2017 |
| Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging E Giannetta, AM Isidori, N Galea, I Carbone, E Mandosi, CD Vizza, F Naro, ... Circulation 125 (19), 2323-2333, 2012 | 214 | 2012 |
| Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension–targeted therapy: the EURO-MR Study AJ Peacock, S Crawley, L McLure, KG Blyth, CD Vizza, R Poscia, ... Circulation: Cardiovascular Imaging 7 (1), 107-114, 2014 | 186 | 2014 |
| Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey S Meyer, VV McLaughlin, HJ Seyfarth, TM Bull, CD Vizza, ... European Respiratory Journal 41 (6), 1302-1307, 2013 | 176 | 2013 |
| COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension MM Hoeper, C Pausch, KM Olsson, D Huscher, D Pittrow, E Grünig, ... European Respiratory Journal 60 (1), 2022 | 164 | 2022 |
| RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors MM Hoeper, G Simonneau, PA Corris, HA Ghofrani, JR Klinger, ... European Respiratory Journal 50 (3), 2017 | 156 | 2017 |
| Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2 M Humbert, JG Coghlan, HA Ghofrani, F Grimminger, JG He, ... Annals of the Rheumatic Diseases 76 (2), 422-426, 2017 | 151 | 2017 |
| Long-term safety and efficacy of imatinib in pulmonary arterial hypertension AE Frost, RJ Barst, MM Hoeper, HJ Chang, RP Frantz, Y Fukumoto, ... The Journal of Heart and Lung Transplantation 34 (11), 1366-1375, 2015 | 136 | 2015 |
| Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry MM Hoeper, C Pausch, E Grünig, H Klose, G Staehler, D Huscher, ... The Journal of Heart and Lung Transplantation 39 (12), 1435-1444, 2020 | 128 | 2020 |
| Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial P Vitulo, A Stanziola, M Confalonieri, D Libertucci, T Oggionni, P Rottoli, ... The Journal of Heart and Lung Transplantation 36 (2), 166-174, 2017 | 125 | 2017 |
| Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension M D’Alto, R Badagliacca, P Argiento, E Romeo, A Farro, S Papa, ... Chest 157 (2), 376-383, 2020 | 121 | 2020 |
